One of the things we talked about on the recent Trialhub webinar about patient feasibility is whether potential trial participants are likely to be motivated to take part.

From inside the industry, we might believe there are legions of eligible patients out there, eager to take part in trials,, if only we could find them.

But the simple fact is, not everyone who could take part in a trial will actually want to.

There are plenty of reasons for this – and obviously we should be doing as much as we can to remove any barriers due to patient burden.

Ultimately, though, it’s a matter of choice for the individual concerned whether they wish to take part or not – something enshrined in the consent process that allows people to withdraw at any time for any reason.

So how do we find out if people might be motivated?

Asking them would probably be a good start.

You may also like

Biotech C-suites Should keep Patient Recruitment in Mind from the Outset
In biotech, a strong C-suite isn’t just about job titles - it’s about covering every part of the journey from discovery to delivery. Including being prepared to tackle one of the biggest ...
Key C-suite Roles for Biotech Success - The Chief Patient Recruitment Officer (CPRO)
While biotech companies have built C-suites with scientific, medical, financial, operational, and business expertise, a critical function has remained conspicuously absent - addressing one ...
Key C-suite Roles for Biotech Success - The Chief Business Officer (CBO)
The Chief Business Officer leads external strategy - licensing deals, identifying pharma partnerships, and developing long-term growth planning and market positioning strategies that ...